Schedule 13D ownership disclosure

Mirum Pharmaceuticals Inc

Security class unavailable · CUSIP: 604749101

Event date: 2019-07-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-204056
Form type
SC 13D
Filer
Frazier Life Sciences IX, L.P.
CIK
CIK 1720320
Filed
Jul 26, 2019
Reporting period
Jul 17, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub